循環型D,L-α-ペプチド構造に基づく抗菌剤
S Fernandez-Lopez1, H S Kim, E C Choi
1Present address: Departamento de Química Orgánica, Universidad de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
Nature
|July 27, 2001
まとめ
新しいサイクルペプチドは,薬剤耐性細菌に対する強力な抗菌活性を示しています. これらの化合物は選択的に細菌膜を標的とし,感染と抗生物質耐性を克服するために有望な新しい治療戦略を提供します.
科学分野:
- バイオケミストリー バイオケミストリー
- 微生物学 微生物学とは
- ドラッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー・ドリッグ・ディスカバリー
背景:
- 抗生物質耐性細菌感染症の増加は,新しい治療アプローチを必要とします.
- 既存の抗生物質は,耐性および有効性の制限により,課題に直面しています.
研究 の 目的:
- 循環型d,l-α-ペプチドの抗菌の可能性を調査する.
- 哺乳類の細胞に対して細菌の膜に対する選択性を評価する.
主な方法:
- 6および8残基のサイクルd,l-α-ペプチドを合成した.
- バクテリアの膜透過性とイオンポテンシャルの変化を評価した.
- マウスモデルでメチチリン耐性黄金球菌 (MRSA) に対する有効性を試験した.
主要な成果:
- 循環型d,l-α-ペプチドは,グラム陽性およびグラム陰性細菌に対して好ましい活性を示した.
- これらのペプチドはバクテリア膜の透過性を高め,膜横断イオンポテンシャルを崩壊させ,急速な細胞死につながった.
- マウスにおける致死性MRSA感染の治療において,高い有効性が観察されました.
結論:
- 循環型d,l-α-ペプチドは,薬剤耐性細菌と戦う可能性のある有効で選択的な抗菌剤です.
- タンパク質分解の安定性と合成の容易さは,それらを魅力的な治療候補にしています.
- これらの新しいペプチドは,既存の抗生物質を補完し,さらなる耐性の発生を緩和するのに役立ちます.
関連する概念動画
Antimicrobial Proteins
10.6K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Bacterial Cell Wall
5.4K
The bacterial cell wall is an essential structural component that encases the plasma membrane, preserving cellular integrity, determining shape, and protecting against osmotic stress. This rigid yet flexible structure primarily comprises peptidoglycan, a polymer that forms a mesh-like matrix conferring mechanical strength and flexibility.Peptidoglycan Composition and StructurePeptidoglycan, the core of the bacterial cell wall, comprises alternating units of N-acetylglucosamine (NAG) and...
5.4K
Peptidoglycan Synthesis
4.7K
Structure of PeptidoglycanPeptidoglycan is a vital structural component of the bacterial cell wall, providing mechanical strength and shape to the cell. It consists of repeating units of two sugars—N-acetylglucosamine (NAG) and N-acetylmuramic acid (NAM)—linked by β-1,4 glycosidic bonds. These sugar chains are cross-linked by short peptide chains, forming a mesh-like polymer that surrounds the bacterial plasma membrane.Cytoplasmic Phase – Precursor SynthesisPeptidoglycan...
4.7K
Inhibitors of Gram-positive Cell Wall Synthesis
190
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
190
Inhibitors of Bacterial Protein Synthesis
106
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Inhibitors of Bacterial DNA Synthesis
128
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
128


